Johnson & Johnson Invests Over $1 Billion in Jacksonville Vision Manufacturing as 2028 Facility Nears
Updated
Updated · Johnson & Johnson · Jun 15
Johnson & Johnson Invests Over $1 Billion in Jacksonville Vision Manufacturing as 2028 Facility Nears
3 articles · Updated · Johnson & Johnson · Jun 15
Summary
More than $1 billion will go into Johnson & Johnson’s Jacksonville vision business, adding advanced manufacturing and packaging technology plus a new distribution center for ACUVUE contact lenses.
Construction is already underway, with the new facility targeted to be fully operational in 2028 as J&J expands U.S.-based capacity, strengthens supply-chain resilience and serves more than 40 million patients.
Jacksonville is a major existing hub for the company, which makes more than 1.7 billion ACUVUE lenses annually there and says the expansion supports 3,500 local employees.
The project sits within Johnson & Johnson’s broader $55 billion U.S. commitment through early 2029 and builds on its roughly $6 billion annual economic impact in Florida.
As global vision problems surge, why is J&J's billion-dollar solution focused so heavily on a single U.S. city?
Will a billion-dollar factory upgrade lead to a breakthrough in contact lens comfort for millions of users?
$1 Billion Investment: How Johnson & Johnson Is Reinforcing Vision Care Manufacturing in Jacksonville, Florida
Overview
Johnson & Johnson is investing $1 billion to expand its vision manufacturing facility in Jacksonville, Florida, as part of a larger $55 billion commitment to U.S. manufacturing, research, and technology through 2029. This major project will strengthen the supply chain for critical vision products, support domestic capacity, and improve patient care. The expansion is expected to create high-quality jobs and boost the skilled workforce in Northeast Florida. By enhancing its advanced manufacturing capabilities, Johnson & Johnson is helping to solidify Jacksonville’s reputation as a leading center for healthcare innovation and economic growth.